These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

567 related items for PubMed ID: 33470844

  • 1. Effect of antimicrobials on Stenotrophomonas maltophilia biofilm.
    Santos Carvalhais BE, Souza E Silva C, Dos Santos KV.
    Future Microbiol; 2021 Jan; 16(2):83-93. PubMed ID: 33470844
    [Abstract] [Full Text] [Related]

  • 2. Drug Resistance in Biofilm and Planktonic Cells of Achromobacter spp., Burkholderia spp., and Stenotrophomonas maltophilia Clinical Isolates.
    Montoya-Hinojosa EI, Villarreal-Treviño L, Bocanegra-Ibarias P, Camacho-Ortiz A, Flores-Treviño S.
    Microb Drug Resist; 2024 Sep; 30(9):354-362. PubMed ID: 39029506
    [Abstract] [Full Text] [Related]

  • 3. Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.
    Biagi M, Tan X, Wu T, Jurkovic M, Vialichka A, Meyer K, Mendes RE, Wenzler E.
    J Clin Microbiol; 2020 Jan 28; 58(2):. PubMed ID: 31748318
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
    Wei C, Ni W, Cai X, Zhao J, Cui J.
    PLoS One; 2016 Jan 28; 11(3):e0152132. PubMed ID: 26999818
    [Abstract] [Full Text] [Related]

  • 5. Biofilm Eradication of Stenotrophomonas maltophilia by Levofloxacin and Trimethoprim-Sulfamethoxazole.
    Río-Chacón JMD, Rojas-Larios F, Bocanegra-Ibarias P, Salas-Treviño D, Espinoza-Gómez F, Camacho-Ortiz A, Flores-Treviño S.
    Jpn J Infect Dis; 2024 Jul 23; 77(4):213-219. PubMed ID: 38296539
    [Abstract] [Full Text] [Related]

  • 6. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
    Chong SY, Lee K, Chung HS, Hong SG, Suh Y, Chong Y.
    Microb Drug Resist; 2017 Mar 23; 23(2):163-168. PubMed ID: 27294684
    [Abstract] [Full Text] [Related]

  • 7. Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime.
    Di Bonaventura G, Spedicato I, D'Antonio D, Robuffo I, Piccolomini R.
    Antimicrob Agents Chemother; 2004 Jan 23; 48(1):151-60. PubMed ID: 14693533
    [Abstract] [Full Text] [Related]

  • 8. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.
    Hu LF, Gao LP, Ye Y, Chen X, Zhou XT, Yang HF, Liiu YY, Mei Q, Li JB.
    J Chemother; 2014 Oct 23; 26(5):282-6. PubMed ID: 24588423
    [Abstract] [Full Text] [Related]

  • 9. Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary.
    Juhász E, Pongrácz J, Iván M, Kristóf K.
    Acta Microbiol Immunol Hung; 2015 Sep 23; 62(3):295-305. PubMed ID: 26551572
    [Abstract] [Full Text] [Related]

  • 10. Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital.
    Gallo SW, Figueiredo TP, Bessa MC, Pagnussatti VE, Ferreira CA, Oliveira SD.
    Microb Drug Resist; 2016 Dec 23; 22(8):688-695. PubMed ID: 27007167
    [Abstract] [Full Text] [Related]

  • 11. Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia.
    Biagi M, Vialichka A, Jurkovic M, Wu T, Shajee A, Lee M, Patel S, Mendes RE, Wenzler E.
    Antimicrob Agents Chemother; 2020 Aug 20; 64(9):. PubMed ID: 32571820
    [Abstract] [Full Text] [Related]

  • 12. Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients.
    Wang CH, Yu CM, Hsu ST, Wu RX.
    J Hosp Infect; 2020 Jan 20; 104(1):46-52. PubMed ID: 31505224
    [Abstract] [Full Text] [Related]

  • 13. Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico.
    Herrera-Heredia SA, Pezina-Cantú C, Garza-González E, Bocanegra-Ibarias P, Mendoza-Olazarán S, Morfín-Otero R, Camacho-Ortiz A, Villarreal-Treviño L, Rodríguez-Noriega E, Paláu-Davila L, Maldonado-Garza HJ, Flores-Treviño S.
    J Med Microbiol; 2017 Aug 20; 66(8):1102-1109. PubMed ID: 28771141
    [Abstract] [Full Text] [Related]

  • 14. Antibiotics resistance of Stenotrophomonas maltophilia strains isolated from various clinical specimens.
    Çıkman A, Parlak M, Bayram Y, Güdücüoğlu H, Berktaş M.
    Afr Health Sci; 2016 Mar 20; 16(1):149-52. PubMed ID: 27358626
    [Abstract] [Full Text] [Related]

  • 15. Temperature, pH and Trimethoprim-Sulfamethoxazole Are Potent Inhibitors of Biofilm Formation by Stenotrophomonas maltophilia Clinical Isolates.
    Biočanin M, Madi H, Vasiljević Z, Kojić M, Jovčić B, Lozo J.
    Pol J Microbiol; 2017 Dec 04; 66(4):433-438. PubMed ID: 29319523
    [Abstract] [Full Text] [Related]

  • 16. In vitro combination of tigecycline with other antibiotics in Stenotrophomonas maltophilia isolates.
    Karamanlıoğlu D, Dizbay M.
    Turk J Med Sci; 2019 Apr 18; 49(2):683-686. PubMed ID: 30866602
    [Abstract] [Full Text] [Related]

  • 17. In vitro susceptibilities of Stenotrophomonas maltophilia isolates to antimicrobial agents commonly used for related infections: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2004-2020.
    Lee YL, Liu CE, Ko WC, Hsueh PR.
    Int J Antimicrob Agents; 2023 Aug 18; 62(2):106878. PubMed ID: 37285926
    [Abstract] [Full Text] [Related]

  • 18. In vitro antibacterial and antibiofilm activities of chlorogenic acid against clinical isolates of Stenotrophomonas maltophilia including the trimethoprim/sulfamethoxazole resistant strain.
    Karunanidhi A, Thomas R, van Belkum A, Neela V.
    Biomed Res Int; 2013 Aug 18; 2013():392058. PubMed ID: 23509719
    [Abstract] [Full Text] [Related]

  • 19. A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia.
    Wei C, Ni W, Cai X, Cui J.
    Infect Dis (Lond); 2015 Aug 18; 47(12):846-51. PubMed ID: 26167850
    [Abstract] [Full Text] [Related]

  • 20. [Investigation of the presence of class 1, 2, 3 integrons and their relationships with antibiotic resistance in clinical Stenotrophomonas maltophilia isolates].
    Usta E, Eroğlu C, Yanık K, Karadağ A, Güney AK, Günaydın M.
    Mikrobiyol Bul; 2015 Jan 18; 49(1):35-46. PubMed ID: 25706729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.